1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. UNITED THERAPEUTICS CORP
United Therapeutics Corp XNAS: UTHR
405.02 0.18 (0.04%)
626.4K
XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Insider Trade
Martine Rothblatt, Chairperson & CEO of United Therapeutics, sells 8K shares worth $3.2 million See details

US Politician trade disclosures for United Therapeutics Corp from August 13, 2025 to September 13, 2025

Representative Lisa McClain discloses a trade of $1K-15K in United Therapeutics Corp, made on August 13, 2025.

Members of Congress or their families often buy or sell securities and have access to non-public information through their roles. The STOCK Act requires them to report these trades within 45 days to ensure transparency and reduce conflicts of interest.